Go to deals
Healthcare

Thubilux Pharma SpA has received a structured loan of US$2.7 million from a leading Italian bank

Tubilux Pharma SpA has successfully raised funds through a structured loan from Cassa Depositi e Prestiti SpA and Banca Intesa San Paolo SpA to support an investment plan for a new production facility which has all the FDA requirements to enter the USA market.

Tubilux Pharma is a leading, privately-held ophthalmic and pharmaceuticals company that develops and markets a range of proprietary, over-the-counter, and branded generic products, with distribution in approximately 30 countries. The firm's customers are large multinational pharmaceutical companies that outsource their production of ophthalmic products to specialized manufactures through medium-term supply contracts (3-5 years).

Oaklins' team in Italy advised Thubilux Pharma SpA in the structuring, negotiation and closing of a long-term debt financing from a leading Italian bank, backed by Cassa Depositi e Prestiti.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Federico  Cappa

Federico Cappa

Partner

Milan, Italy
Oaklins Italy
 Marie Gabriella  Sestini

Marie Gabriella Sestini

Associate

Turin, Italy
Oaklins Italy

Related deals

BlijWerkt has been acquired by Mentha Capital
Business Support Services | Healthcare | Private Equity

BlijWerkt has been acquired by Mentha Capital

Gilde Healthcare Partners has sold BlijWerkt Groep B.V. to Mentha Capital.

Learn more
Lead Healthcare has successfully raised financing provided by Rabobank
Healthcare

Lead Healthcare has successfully raised financing provided by Rabobank

Lead Healthcare has successfully raised financing provided by Rabobank.

Learn more
ERBC (ex CERB) has acquired RTC
Healthcare

ERBC (ex CERB) has acquired RTC

The European Research Biology Center (ERBC) has acquired the Research Toxicology Center (RTC).

Learn more